Thrombospondins	0	15	B-Gene_or_gene_product
,	15	16	O
metallo	17	24	B-Gene_or_gene_product
proteases	25	34	I-Gene_or_gene_product
and	35	38	O
thrombospondin	39	53	B-Gene_or_gene_product
receptors	54	63	I-Gene_or_gene_product
messenger	64	73	O
RNA	74	77	O
and	78	81	O
protein	82	89	O
expression	90	100	O
in	101	103	O
different	104	113	O
tumour	114	120	B-Pathological_formation
sublines	121	129	I-Pathological_formation
of	130	132	O
the	133	136	O
Dunning	137	144	B-Pathological_formation
prostate	145	153	I-Pathological_formation
cancer	154	160	I-Pathological_formation
model	161	166	I-Pathological_formation
.	166	167	O

Thrombospondin	169	183	B-Gene_or_gene_product
is	184	186	O
a	187	188	O
potent	189	195	O
inhibitor	196	205	O
of	206	208	O
angiogenesis	209	221	O
and	222	225	O
might	226	231	O
therefore	232	241	O
be	242	244	O
important	245	254	O
in	255	257	O
controlling	258	269	O
tumour	270	276	B-Pathological_formation
growth	277	283	O
.	283	284	O

TSP	285	288	B-Gene_or_gene_product
interacts	289	298	O
with	299	303	O
a	304	305	O
number	306	312	O
of	313	315	O
proteases	316	325	O
and	326	329	O
receptors	330	339	O
and	340	343	O
in	344	346	O
this	347	351	O
way	352	355	O
inhibits	356	364	O
stimulation	365	376	O
of	377	379	O
angiogenesis	380	392	O
.	392	393	O

An	394	396	O
earlier	397	404	O
study	405	410	O
showed	411	417	O
that	418	422	O
thrombospondin	423	437	B-Gene_or_gene_product
is	438	440	O
expressed	441	450	O
in	451	453	O
benign	454	460	O
prostatic	461	470	O
hyperplasia	471	482	O
(	483	484	O
BPH	484	487	O
)	487	488	O
and	489	492	O
high	493	497	O
-	497	498	O
grade	498	503	O
prostatic	504	513	O
intraepithelial	514	529	O
neoplasia	530	539	O
(	540	541	O
PIN	541	544	O
)	544	545	O
but	546	549	O
is	550	552	O
absent	553	559	O
in	560	562	O
prostate	563	571	B-Pathological_formation
cancer	572	578	I-Pathological_formation
.	578	579	O

The	580	583	O
present	584	591	O
study	592	597	O
was	598	601	O
therefore	602	611	O
designed	612	620	O
to	621	623	O
evaluate	624	632	O
the	633	636	O
expression	637	647	O
of	648	650	O
thrombospondin	651	665	B-Gene_or_gene_product
1	666	667	I-Gene_or_gene_product
and	668	671	O
2	672	673	B-Gene_or_gene_product
(	674	675	O
TSP	675	678	B-Gene_or_gene_product
-	678	679	I-Gene_or_gene_product
1	679	680	I-Gene_or_gene_product
,	680	681	O
TSP	682	685	B-Gene_or_gene_product
-	685	686	I-Gene_or_gene_product
2	686	687	I-Gene_or_gene_product
)	687	688	O
,	688	689	O
TSP	690	693	B-Gene_or_gene_product
receptors	694	703	O
CD36	704	708	B-Gene_or_gene_product
and	709	712	O
CD47	713	717	B-Gene_or_gene_product
,	717	718	O
and	719	722	O
matrix	723	729	B-Gene_or_gene_product
-	729	730	I-Gene_or_gene_product
metalloproteases	730	746	I-Gene_or_gene_product
2	747	748	I-Gene_or_gene_product
and	749	752	O
9	753	754	B-Gene_or_gene_product
(	755	756	O
MMP	756	759	B-Gene_or_gene_product
-	759	760	O
,	760	761	O
MMP	762	765	B-Gene_or_gene_product
-	765	766	I-Gene_or_gene_product
9	766	767	I-Gene_or_gene_product
)	767	768	O
in	769	771	O
a	772	773	O
rat	774	777	B-Organism
prostate	778	786	B-Pathological_formation
cancer	787	793	I-Pathological_formation
model	794	799	O
.	799	800	O

By	801	803	O
using	804	809	O
immunohistochemistry	810	830	O
,	830	831	O
Western	832	839	O
blot	840	844	O
,	844	845	O
and	846	849	O
real	850	854	O
-	854	855	O
time	855	859	O
PCR	860	863	O
the	864	867	O
expression	868	878	O
patterns	879	887	O
of	888	890	O
TSP	891	894	B-Gene_or_gene_product
-	894	895	I-Gene_or_gene_product
1	895	896	I-Gene_or_gene_product
,	896	897	O
TSP	898	901	B-Gene_or_gene_product
-	901	902	I-Gene_or_gene_product
2	902	903	I-Gene_or_gene_product
,	903	904	O
CD36	905	909	B-Gene_or_gene_product
,	909	910	O
CD47	911	915	B-Gene_or_gene_product
,	915	916	O
MMP	917	920	B-Gene_or_gene_product
-	920	921	I-Gene_or_gene_product
2	921	922	I-Gene_or_gene_product
,	922	923	O
and	924	927	O
MMP	928	931	B-Gene_or_gene_product
-	931	932	I-Gene_or_gene_product
9	932	933	I-Gene_or_gene_product
were	934	938	O
investigated	939	951	O
in	952	954	O
normal	955	961	O
rat	962	965	B-Organism
prostate	966	974	B-Tissue
tissue	975	981	I-Tissue
and	982	985	O
five	986	990	O
malignant	991	1000	B-Tissue
Dunning	1001	1008	I-Tissue
sublines	1009	1017	I-Tissue
tissue	1018	1024	I-Tissue
.	1024	1025	O

TSP	1026	1029	B-Gene_or_gene_product
-	1029	1030	I-Gene_or_gene_product
1	1030	1031	I-Gene_or_gene_product
mRNA	1032	1036	O
levels	1037	1043	O
were	1044	1048	O
decreased	1049	1058	O
in	1059	1061	O
all	1062	1065	O
tumours	1066	1073	B-Pathological_formation
compared	1074	1082	O
with	1083	1087	O
normal	1088	1094	O
prostate	1095	1103	B-Organ
.	1103	1104	O

However	1105	1112	O
,	1112	1113	O
there	1114	1119	O
was	1120	1123	O
no	1124	1126	O
difference	1127	1137	O
in	1138	1140	O
expression	1141	1151	O
of	1152	1154	O
TSP	1155	1158	B-Gene_or_gene_product
-	1158	1159	I-Gene_or_gene_product
2	1159	1160	I-Gene_or_gene_product
and	1161	1164	O
CD36	1165	1169	B-Gene_or_gene_product
mRNA	1170	1174	O
in	1175	1177	O
these	1178	1183	O
samples	1184	1191	O
.	1191	1192	O

MMP	1193	1196	B-Gene_or_gene_product
-	1196	1197	I-Gene_or_gene_product
2	1197	1198	I-Gene_or_gene_product
was	1199	1202	O
increased	1203	1212	O
with	1213	1217	O
malignancy	1218	1228	O
,	1228	1229	O
but	1230	1233	O
no	1234	1236	O
expression	1237	1247	O
of	1248	1250	O
MMP	1251	1254	B-Gene_or_gene_product
-	1254	1255	I-Gene_or_gene_product
9	1255	1256	I-Gene_or_gene_product
was	1257	1260	O
seen	1261	1265	O
.	1265	1266	O

The	1267	1270	O
CD47	1271	1275	B-Gene_or_gene_product
receptor	1276	1284	I-Gene_or_gene_product
did	1285	1288	O
slightly	1289	1297	O
increase	1298	1306	O
with	1307	1311	O
malignancy	1312	1322	O
except	1323	1329	O
for	1330	1333	O
H3327	1334	1339	B-Pathological_formation
.	1339	1340	O

The	1341	1344	O
results	1345	1352	O
showed	1353	1359	O
that	1360	1364	O
thrombospondin	1365	1379	B-Gene_or_gene_product
is	1380	1382	O
expressed	1383	1392	O
in	1393	1395	O
normal	1396	1402	O
prostate	1403	1411	B-Organ
but	1412	1415	O
not	1416	1419	O
in	1420	1422	O
prostate	1423	1431	B-Pathological_formation
tumours	1432	1439	I-Pathological_formation
in	1440	1442	O
a	1443	1444	O
rat	1445	1448	B-Organism
model	1449	1454	O
.	1454	1455	O

Simultaneously	1456	1470	O
,	1470	1471	O
MMP	1472	1475	B-Gene_or_gene_product
-	1475	1476	I-Gene_or_gene_product
2	1476	1477	I-Gene_or_gene_product
expression	1478	1488	O
increases	1489	1498	O
with	1499	1503	O
malignancy	1504	1514	O
.	1514	1515	O

